Search

everythinglearnresearchcommunity

for

Search:↓

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Early hair graying is often inherited and influenced by genetics, environment, and lifestyle, but treatment options are limited.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Hair regrowth improved, but quality of life did not.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Laser treatments are the most effective for porokeratotic adnexal ostial nevus.

Alopecia areata management involves explaining the condition, using treatments like steroids and immunotherapy, and providing support like counseling and wigs.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Alopecia areata may be linked to kidney issues, but more research is needed.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

A man developed severe skin reactions after using a treatment for hair loss.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Cromolyn sodium oleate gel is more effective and safer for treating atopic dermatitis than dexamethasone.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

The woman's widespread skin condition did not improve despite various treatments.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

Prolonged use of topical corticosteroids can cause excessive hair growth.